Literature DB >> 8092834

Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.

E Martin1, F Maier, S Bhakdi.   

Abstract

This study addressed the effects of fluconazole and 5-fluorocytosine on the candidacidal activity of amphotericin B in the presence of human serum. A Candida albicans isolate that was susceptible to all three agents according to standard testing procedures was employed. Fungicidal activity was estimated by using a flow cytometric procedure that exploited the fact that yeast cells killed by amphotericin B diminish in size and take up propidium iodide. The following findings were made. (i) Fluconazole and 5-fluorocytosine each failed to inhibit pseudohyphal formation and cell aggregation even when applied at 10 and 50 micrograms/ml, respectively, for up to 10 h. Hence, these agents were not fungistatic when tested in the presence of serum. (ii) Simultaneous application of 5-fluorocytosine had neither enhancing nor inhibitory effects on the fungicidal activity of amphotericin B. However, yeasts that were preincubated for 20 h with 5-fluorocytosine became less susceptible to killing by amphotericin B. (iii) Fluconazole exerted a frank antagonistic effect on the fungicidal activity of amphotericin B. Thus, under our in vitro conditions, both fluconazole and 5-fluorocytosine can overtly antagonize the candidacidal action of amphotericin B.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092834      PMCID: PMC188207          DOI: 10.1128/AAC.38.6.1331

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Synergism of amphotericin B and 5-fluorocytosine for candida species.

Authors:  J Z Montgomerie; J E Edwards; L B Guze
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole.

Authors:  R F Cosgrove; A E Beezer; R J Miles
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

3.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

4.  Letter: Antagonism between miconazole and amphotericin B.

Authors:  L P Schacter; R J Owellen; H K Rathbun; B Buchanan
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

5.  Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.

Authors:  W H Beggs; F A Andrews; G A Sarosi
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

6.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

7.  Rubidium release: a rapid and sensitive assay for amphotericin B.

Authors:  R E Drazin; R I Lehrer
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

8.  Amphotericin B pharmacokinetics in humans.

Authors:  A J Atkinson; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.

Authors:  J Brajtburg; D Kobayashi; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

10.  Synergism of polyene antibiotics with 5-fluorocytosine.

Authors:  A Polak
Journal:  Chemotherapy       Date:  1978       Impact factor: 2.544

View more
  16 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.

Authors:  A Louie; P Kaw; P Banerjee; W Liu; G Chen; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms.

Authors:  Nermin H Ibrahim; Nahla A Melake; Ali M Somily; Azza S Zakaria; Manal M Baddour; Amany Z Mahmoud
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

4.  Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.

Authors:  A Louie; W Liu; D A Miller; A C Sucke; Q F Liu; G L Drusano; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

5.  Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.

Authors:  A Louie; P Banerjee; G L Drusano; M Shayegani; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 6.  Use of amphotericin B with azole antifungal drugs: what are we doing?

Authors:  A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability.

Authors:  L J Green; P Marder; L L Mann; L C Chio; W L Current
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.

Authors:  B Jahn; E Martin; A Stueben; S Bhakdi
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.

Authors:  B Jahn; A Stüben; S Bhakdi
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.

Authors:  R E Lewis; B C Lund; M E Klepser; E J Ernst; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.